About 1849 Bio - Innovative Business Model and Vision
1849 Bio engineers microbes to extract metals from low-grade copper and gold ores that conventional mining methods cannot process economically or easily. Much of the copper held in the earth exists as chalcopyrite, yet a passivating layer that forms on its surface prevents it from dissolving in conventional leaching processes, leaving these deposits untouched.
As copper-intensive industries such as electric vehicles and renewable energy expand, copper supply shortages are intensifying. By offering a route to vast mineral reserves that could not previously be monetized, 1849 Bio aims to address one of the central challenges of the energy transition while creating substantial economic value.
The company’s competitive advantage lies in treating the microbe itself as an object of design. Where existing approaches depend on chemical additives or strains found in nature, 1849 Bio engineers strains directly to break down the target ore. That capability rests on a founding team that researched bioengineering and microbiology at MIT and has already commercialized engineered microbes as real products in agriculture. Rather than owning mines, the company layers its technology onto the extraction processes of mines already in operation and earns a royalty on the metals recovered — a model through which it seeks to transform long-established mining practice.
